| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CID/CIX186 |
| P698 | PubMed publication ID | 28329088 |
| P50 | author | Tom van der Poll | Q63136192 |
| Marc J. M. Bonten | Q87138620 | ||
| Nicole P Juffermans | Q88062370 | ||
| Peter M C Klein Klouwenberg | Q91926116 | ||
| P2093 | author name string | David S Y Ong | |
| Olaf L Cremer | |||
| MARS consortium | |||
| Jos F Frencken | |||
| P2860 | cites work | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 |
| Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 | ||
| Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock | Q34597640 | ||
| Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study | Q36035706 | ||
| A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study | Q37766420 | ||
| Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). | Q38070006 | ||
| Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk | Q38090988 | ||
| Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients | Q38127087 | ||
| Acute kidney injury-epidemiology, outcomes and economics | Q38180360 | ||
| Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 | ||
| Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis. | Q40474926 | ||
| A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis. | Q40689023 | ||
| The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs | Q41110594 | ||
| Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations | Q41348554 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| gentamicin | Q422482 | ||
| septic shock | Q1765564 | ||
| P304 | page(s) | 1731-1736 | |
| P577 | publication date | 2017-02-28 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study | |
| P478 | volume | 64 |
| Q91793245 | An approach to antibiotic treatment in patients with sepsis |
| Q90392148 | Antibiotic Thresholds for Sepsis and Septic Shock |
| Q98170152 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis |
| Q89669079 | Bloodstream infections in critically ill patients: an expert statement |
| Q61812041 | Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department |
| Q92156716 | Reply to Raoult and Rolain, and to Echols and Tillotson |
| Q50090246 | Short Course of Empirical Gentamicin in Patients With Severe Sepsis and Septic Shock in the ICU: A Benefit or a Burden? |
| Q41987148 | Should the aminoglycoside β-lactam combination be abandoned in all severely ill patients with presumed Gram-negative infection? |
| Q89414736 | Surviving sepsis campaign: research priorities for sepsis and septic shock |
| Q55263163 | The Rapid Prediction of Carbapenem Resistance in Patients With Klebsiella pneumoniae Bacteremia Using Electronic Medical Record Data. |
| Q52695014 | Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. |
| Q47129727 | Update on ventilator-associated pneumonia. |
| Q64229824 | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
Search more.